# Role of NFKBIA and PTPN22 Genes Polymorphism in Acute Rejection Susceptibility After Living Donor Liver Transplantation in Egyptian Patients.

> **NCT06060808** · — · COMPLETED · sponsor: **Helwan University** · enrollment: 105 (actual)

## Conditions studied

- Liver Transplant Rejection

## Interventions

- **GENETIC:** gene polymorphism

## Key facts

- **NCT ID:** NCT06060808
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2023-04-23
- **Final completion:** 2023-07-24
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2023-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06060808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06060808, "Role of NFKBIA and PTPN22 Genes Polymorphism in Acute Rejection Susceptibility After Living Donor Liver Transplantation in Egyptian Patients.". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06060808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*